Case Study
Volume 9 Issue 7 - 2020
Diagnosis and Treatment of Pulmonary Embolism for Patients with Cancer: Better Outcomes Result from Earlier Detection
Nischal Chennuru1* and Elizabeth Kwo2*
1Columbus, OH, USA
2Preventative Care and Occupational Medicine Physician, Harvard Medical School, Boston, USA
*Corresponding Author: Nischal Chennuru, Columbus, OH, USA.
Received: June 01, 2020; Published: July 16, 2020




Abstract

Risk of pulmonary embolism (PE) is relatively high in patients with malignancies. It can happen with any cancer and the incidence is further increased by treatment modalities including surgery, chemotherapy and radiation and is also affected by disease progression. Pulmonary embolism can manifest initially without symptoms but also occur as life-threatening cardiogenic shock. Diagnosis is usually confirmed by CT angiogram but algorithms to determine the pretest probability of PE using several noninvasive tests including D-dimer and EKGs, chest x-ray. Mortality of untreated pulmonary embolism is very high. Treatment of pulmonary embolism is dependent upon the symptoms and the burden of the clot which can vary from only anticoagulation to requiring thrombolytic therapy or surgical embolectomy.

Keywords: Pulmonary Embolism (PE); CT Angiogram; D-Dimer; EKGs, Chest X-Ray

References

  1. Marta Biedka., et al. “Acute pulmonary embolus in the course of cancer”. Contemporary Oncology 5 (2012): 388-393.
  2. Liu Junjin., et al. “Prognosis and risk factors in older patients with lung cancer and pulmonary embolism A propensity score matching analysis”. Nature Journal (2020): 1272.
  3. Michael B Streiff. “Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients”. Clinical Advances in Hematology and Oncology6 (2013).
  4. Khorana AA., et al. “Thromboembolism in hospitalized neutropenic cancer patients”. Journal of Clinical Oncology 24 (2006): 484-490.
  5. Khorana AA., et al. “Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients”. Cancer 110 (2007): 2339-2346.
  6. Stein PD., et al. “Incidence of venous thromboembolism in patients hospitalized with cancer”. The American Journal of Medicine 119 (2006): 60-68.
  7. Blom JW., et al. “Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study”. Journal of Thrombosis and Haemostasis 4 (2006): 529-535.
  8. Biedka M., et al. “Choroba zakrzepowo-zatorowa w przebiegu choroby nowotworowej”. Onkol Radioter 3 (2012): 43-51.
  9. Lugassy G., et al. “Zakrzepica a nowotwory”. Wyd. Warszawa: Medipage (2006):1-255.
  10. Ziółkowska E. “Wpływ leczenia energią promienistą na układ fibrynolityczny osocza chorych na raka płuca. Rozprawa doktorska, Akademia Medyczna im”. Ludwika Rydygiera w Bydgoszczy (1999): 9-10.
  11. Jassem E. “Zatorowość płucna”. Polska Medycyna Paliatywna 2 (2003): 93-98.
  12. Biedka M., et al. “Choroba zakrzepowo-zatorowa w przebiegu choroby nowotworowej”. Onkol Radioter 3 (2012): 43-51.
  13. Budaj A. “Ostra zatorowość płucna - jak rozpoznawać, leczyć i skutecznie zapobiegać innym epizodom”. Przew Lek 7 (2007): 53-61.
  14. Lake DR., et al. “Computed tomography an pulmonary embolus: a review”. Seminars in Ultrasound, CT and MRI 26 (2005): 270-280.
  15. Alastair JE Moore., et al. “Imaging of Acute Pulmonary Embolism: An Update”. Cardiovascular Diagnosis and Therapy 3 (2018): 225-243.
  16. White CS., et al. “Chest pain evaluation in the emergency department: can MDCT provide a comprehensive evaluation?” The American Journal of Roentgenology 185 (2005): 533-540.
  17. Woo JK., et al. “Risk-benefit analysis of pulmonary CT angiography in patients with suspected pulmonary embolus”. The American Journal of Roentgenology 198 (2012): 1332-13329.
  18. Beckett KR., et al. “Safe Use of Contrast Media: What the Radiologist Needs to Know”. Radiographics 35 (2015): 1738-1750.
  19. Katayama H., et al. “Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media”. Radiology 175 (1990): 621-628.
  20. Li X., et al. “Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China”. The British Journal of Radiology 88 (2015): 20140491.
  21. Anderson DR and Barnes DC. “Computerized tomographic pulmonary angiography versus ventilation perfusion lung scanning for the diagnosis of pulmonary embolism”. Current Opinion in Pulmonary Medicine 15 (2009): 425-429.
  22. Parker JA., et al. “SNM practice guideline for lung scintigraphy 4.0”. Journal of Nuclear Medicine Technology 40 (2012): 57-65.
  23. Sinzinger H., et al. “Ventilation/perfusion lung scintigraphy. Multiple applications besides pulmonary embolism”. Hellenic Journal of Nuclear Medicine 16 (2013): 50-55.
  24. Mattsson S., et al. “Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances”. Annals of the ICRP 44 (2015): 7-321.
  25. Einstein AJ., et al. “Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography”. The Journal of the American Medical Association 298 (2007): 317-323.
  26. Reichert M., et al. “Venous thromboembolism: additional diagnostic value and radiation dose of pelvic CT venography in patients with suspected pulmonary embolism”. European Journal of Radiology 80 (2011): 50-53.
  27. Stein PD., et al. “Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators”. Radiology 242 (2007): 15-21.
  28. Stein PD., et al. “Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III)”. Annals of Internal Medicine 152 (2010): 434-443.
  29. Joel T Levis. “ECG Diagnosis: Pulmonary Embolism”. The Permanente Journal.
  30. Grifoni S., et al. “Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction”. Circulation 101 (2000): 2817-2822.
  31. Ribeiro A., et al. “Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate”. American Heart Journal 134 (1997): 479-487.
  32. Geoffrey D Barnes. “Anticoagulation Strategies in Cancer Patients”. American College of Physicians (2019).
  33. Rivera-Lebron B., et al. “Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium”. Clinical and Applied Thrombosis/Hemostasis 25 (2019): 1076029619853037.
  34. Kearon C., et al. “Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report”. Chest 149 (2016): 315-352.
  35. Groetzinger LM., et al. “Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis”. Clinical and Applied Thrombosis/Hemostasis 24 (2018): 908-913.
  36. Wan S., et al. “Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials”. Circulation 110 (2004): 744-749.
  37. Meyer G., et al. “Fibrinolysis for patients with intermediate-risk pulmonary embolism”. The New England Journal of Medicine 370 (2014): 1402-1411.
  38. Konstantinides S., et al. “Comparison of alteplase versus heparin for resolution of major pulmonary embolism”. The American Journal of Cardiology 82 (1998): 966-970.
  39. Wang C., et al. “Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial”. Chest 137 (2010): 254-262.
  40. Bloomer TL., et al. “Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis”. Catheterization and Cardiovascular Interventions 89 (2017): 754-760.
  41. Griffiths GO., et al. “FRAGMATIC: a randomized phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer”. BMC Cancer 9 (2009): 355.
  42. Dolovich LR., et al. “A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency”. Archives of Internal Medicine 160 (2000): 181-188.
  43. Pruszczyk P and Gacionga Z. “Żylna choroba zakrzepowo-zatorowa w praktyce lekarskiej”. Medycyna po Dyplomie 9 (2005): 3-32.
Citation: Nischal Chennuru and Elizabeth Kwo. “Diagnosis and Treatment of Pulmonary Embolism for Patients with Cancer: Better Outcomes Result from Earlier Detection”. EC Pulmonology and Respiratory Medicine 9.8 (2020): 32-39.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 15, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk